Septerna
Septerna is a California-based biopharmaceutical company specializing in the development of proteins that enhance the cellular uptake of therapeutic compounds. The company has recently gained attention for entering a significant collaboration with Novo Nordisk to develop oral medications for the treatment of obesity and diabetes, which could result in payments of up to $2.2 billion depending on the success of the partnership.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Denmark:
Septerna has specialized in developing proteins that can help chemicals be absorbed into cells.
7